Home › Funds › NEXTBio Capital Management LP › ORIC

NEXTBio Capital Management LP position in ORIC

ORIC PHARMACEUTICALS INC · Health Care

NEXTBio Capital Management LP reported holding 684,476 shares of ORIC (ORIC PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$9.2M, representing 4.01% of its reported portfolio and ranking #11 among its reported holdings. NEXTBio Capital Management LP has disclosed ORIC holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)684.48K sh
Reported value held$9.22M
Portfolio Weight4.01%
First reportedQ4 2025
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How NEXTBio Capital Management LP's ORIC position evolved

NEXTBio Capital Management LP first disclosed a stake in ORIC in Q4 2025 at 615,720 shares (US$5.0M). The position peaked in Q3 2026 at 684,476 shares, worth US$9.2M. Across 4 filings, NEXTBio Capital Management LP increased the stake 1 time(s), trimmed it 2 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 684,476 shares valued at US$9.2M — a reduction of -21,648 shares quarter over quarter.. Notable position changes include a 35% increase in Q2 2026 (shares rose 24% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 615.72K $5.04M New
Q1 2026 523.62K $6.63M Reduce
Q2 2026 706.12K $7.65M Add
Q3 2026 684.48K $9.22M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About ORIC and 13F data

ORIC (ORIC PHARMACEUTICALS INC) is a Health Care company. 41 other funds we track also report a position in ORIC — the largest reported positions include Nextech Invest Ltd. (US$77.6M), EcoR1 Capital, LLC (US$72.9M), SR ONE CAPITAL MANAGEMENT, LP (US$50.0M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding ORIC

All ORIC fund holders →

FAQ

How long has NEXTBio Capital Management LP held ORIC?

NEXTBio Capital Management LP has disclosed ORIC holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is NEXTBio Capital Management LP's current position in ORIC?

As of Q3 2026, NEXTBio Capital Management LP holds 684.48K shares of ORIC (ORIC PHARMACEUTICALS INC), valued at $9.22M, representing 4.01% of its reported portfolio and ranking #11.

Has NEXTBio Capital Management LP been buying or selling ORIC?

In the latest 13F filing (Q3 2026), NEXTBio Capital Management LP reduced its position in ORIC. The position peaked in Q3 2026 at 684.48K shares.

Which other funds hold ORIC?

Other major institutional holders of ORIC include Nextech Invest Ltd., EcoR1 Capital, LLC, SR ONE CAPITAL MANAGEMENT, LP, among 41 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.